Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
BTIG lowered its price target for Palo Alto Networks to $200 from $248 while keeping a Buy rating, citing multiple compression across software even as channel checks showed improving demand. The new target implies roughly 21% upside from the current share price. The company has completed its acquisition of CyberArk and several other brokerages have…
Jefferies has shifted its rating on Novo Nordisk to Hold from Underperform after steep cuts to consensus forecasts and a repricing of the stock. The broker lifted its price target to 275 Danish crowns from 270, saying headline pricing pressures and margin concerns have been reflected in consensus estimates. While the U.S. oral Wegovy launch could p…
Viking Therapeutics saw its stock jump 11.63% following an announcement that its investigational oral obesity drug VK2735 will advance into late-stage trials in the third quarter of this year. The company cited late-stage study results showing once-daily oral dosing produced up to 12.2% average weight loss after 13 weeks and emphasized that offerin…
H.C. Wainwright initiated coverage on Immunome Inc. (IMNM) with a Buy rating and a $40.00 price objective, representing a 71% premium to the referenced $23.41 share price. The firm cited the company’s lead candidate varegacestat and a developing ADC franchise as core value drivers, while recent equity financing and upbeat third-party analyst update…
Needham has maintained a Buy rating and a $45.00 price target on AtriCure Inc. (NASDAQ: ATRC) despite the prospect of a new surgical left atrial appendage closure (LAAC) competitor from Edwards Lifesciences. The price target implies roughly 37% upside from the stock's current price of $32.90. Analysts tracked by InvestingPro see somewhat larger ups…
RBC Capital downgraded HubSpot Inc from Outperform to Sector Perform and reduced its price target from $322.00 to $189.00. The new target sits below the current share price and follows a steep share decline over the past year. RBC cited heightened downside risk in the stock's risk/reward profile despite HubSpot's strong margins and recent quarterly…
Clear Street has reiterated a Buy rating and a $6.60 price target on Century Therapeutics (IPSC), pointing to strong potential for CNTY-813 as a cell therapy aimed at treating type 1 diabetes. The firm emphasized Century’s Allo-Evasion hypoimmune edits as a competitive advantage and noted early competitive data supporting the approach. Recent finan…
Oppenheimer has reiterated an Outperform rating and maintained a $15.00 price target on Aurora Innovation Inc (NASDAQ:AUR), even after the company issued 2026 revenue guidance below consensus and signaled higher-than-expected cash burn. The price target implies roughly 244% upside from AUR’s trading level of $4.36, amid recent volatility in the sha…
Baird raised its price target on GlobalFoundries (GFS) to $60 from $40 while keeping an Outperform rating, projecting upside from the current share price near $48.74. The firm points to silicon photonics, satellite and optical networking as near- and medium-term revenue and mix drivers, and highlights continued automotive content gains and share ex…
Restaurant Brands International reported fourth-quarter comparable sales above analyst estimates, supported by steady customer traffic at its Burger King and Tim Hortons chains. The company’s U.S.-listed shares rose about 2% in premarket trading. McDonald’s likewise exceeded expectations for global comparable sales and profit, reporting a 3.1% same…
U.S. January employment data showed payrolls rising by 130,000 versus a 70,000 forecast, while the unemployment rate unexpectedly declined to 4.3% as labor force participation increased and average earnings growth accelerated. Markets reacted by re-pricing expectations for Federal Reserve rate cuts, with two cuts still implied for the year but the …
AppLovin Corp (NASDAQ:APP) saw its stock decline after management's first-quarter revenue outlook fell short of investor expectations, despite the company reporting stronger-than-expected sales and demand for advertising and AI-enabled products in the fourth quarter. Analysts offered mixed reactions, highlighting both execution and competitive head…
BofA Securities has reaffirmed a Buy rating on Royalty Pharma (NASDAQ: RPRX) and kept a $54.00 price target after the company posted robust fourth-quarter results. The target implies roughly 22% upside from the stock's current level, while management issued fiscal 2026 royalty receipt guidance that BofA characterizes as conservative given several d…
William Blair has kept an Outperform rating on ViaSat after Southwest Airlines said it will install SpaceX’s Starlink on more than 300 aircraft this year. The firm says the Starlink rollout replaces Anuvu systems on older planes and does not affect ViaSat equipment on Southwest’s existing fleet; Southwest will continue to fit ViaSat systems on all …
BofA Securities trimmed its Cleveland-Cliffs (CLF) price target to $13.00 from $14.50 and kept a Neutral rating after the steelmaker reported a fourth-quarter earnings miss and provided guidance that disappointed the firm. Weak Q4 adjusted EBITDA, revised 2026 profitability expectations and a stretched balance sheet underpin the cautious stance, wh…
William Blair has reaffirmed an Outperform rating on HubSpot Inc while the stock trades near its 52-week low after a sharp yearlong decline. The firm points to quality quarterly results but signals that a return to meaningful growth or a notable pickup in AI-driven adoption will be required to rebuild investor confidence. Valuation metrics show Hub…
Goldman Sachs updated its coverage of Greece’s major lenders, upgrading Eurobank to buy and downgrading National Bank of Greece to neutral, while keeping buy calls on Piraeus and Alpha Bank. The firm increased price targets across the board, citing a lower cost of capital and more favourable structural profitability for the sector, and outlined key…
Applied Materials fell in premarket trading after Lynx Equity Strategies issued a cautious note ahead of the company's earnings report, warning that market expectations may be overly optimistic and that a DRAM-driven capital expenditure cycle might support absolute growth but may not be enough to close the gap with competitors such as Lam Research.
Barclays trimmed its price target for Unity Software (NYSE:U) to $28 from $35 while keeping an Equalweight rating. The bank cited improving AI-driven world models and advertising scale potential, but said valuation upside may be constrained until key uncertainties are resolved. Unity posted revenue and EBITDA above consensus, reported robust traili…
Bombardier reported a near 19% year-over-year increase in fourth-quarter revenue to $3.69 billion, driven by higher business jet deliveries. The company issued 2026 guidance calling for revenue above $10 billion, free cash flow of $600 million to $1 billion, and more than 157 deliveries, while warning of tariff and trade-policy uncertainty tied to …
BTIG has lowered its one-year price target on AppLovin Corp to $640 from $771 while retaining a Buy rating following the company’s fourth-quarter results. The adjustment reflects sector multiple compression and updated estimates that incorporate 2026 quarterly modeling, despite strong near-term performance, robust margin metrics and constructive gu…
Truist Securities increased its 12-month price target for Genuine Parts Company (GPC) to $162 from $146 and kept a Buy rating, highlighting traction in the industrial segment and ongoing support for the automotive business. The stock is trading just shy of its 52-week high after posting strong year-to-date and one-year returns. Other brokerages hav…
Wolfe Research increased its price objective on Gilead Sciences to $170 from $155 and retained an Outperform rating, pointing to continued strength in the company’s HIV portfolio. The move follows robust product growth, an above-consensus quarterly report, and a string of price-target revisions from other brokerages.
TD Cowen reduced its rating on Rigetti Computing Inc. (RGTI) from Buy to Hold in a research note released Thursday, maintaining a $360 price target but warning that the stock is richly valued and that consensus earnings per share for 2026 may need to be trimmed modestly. The downgrade follows solid fourth-quarter 2025 results and a major $8.4 milli…
Wolfe Research cut its price target for Circle Internet Group (CRCL) to $40 from $65 while maintaining an Underperform rating. The firm pointed to materially lower out-year profitability under its updated model, and InvestingPro data highlights the company’s recent stock decline, negative EBITDA and slim gross margins. Other brokerages provided mix…
